Graham Capital Management »

Adaptimmune Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $12k 13k 0.95

More positions owned by Graham Capital Management

Microstrategy Cl A New Put Option (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Microstrategy Note 2/1 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Vaneck Etf Trust Junior Gold Mine Call Option (GDXJ)
Tilray Brands Note 5.200% 6/1 (Principal)
Novavax Note 5.000%12/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Penn Entertainment Note 2.750% 5/1 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Adaptimmune Therapeutics

Matrix Capital Management Company
EcoR1 Capital
NEA Management Company
Baillie Gifford & Co
Long Focus Capital Management
Partner Fund Management
MPM Asset Management
MPM Oncology Impact Management
Bank of America Corporation
Rock Springs Capital Management
Renaissance Technologies
Jpmorgan Chase & Co
Redmile Group
Marshall Wace
Morgan Stanley

View all funds holding Adaptimmune Therapeutics